Mukhtar, S., & Haris, M. (2023). Teplizumab: an FDA- approved drug, marks milestone in treatment of type 1 diabetes . International Journal of Scientific Reports, 10(1), 29–30. https://doi.org/10.18203/issn.2454-2156.IntJSciRep20233870